What is the treatment for bulimia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Bulimia Nervosa

The American Psychiatric Association recommends that adults with bulimia nervosa be treated with eating disorder-focused cognitive-behavioral therapy (CBT) and a serotonin reuptake inhibitor (fluoxetine 60 mg daily), either initially or if there is minimal or no response to psychotherapy alone by 6 weeks of treatment. 1

Initial Assessment

  • A comprehensive psychiatric evaluation should include weighing the patient, quantifying eating and weight control behaviors (frequency, intensity, time spent on dietary restriction, binge eating, purging, exercise) 1
  • Identify co-occurring psychiatric disorders, which are common in bulimia nervosa 1, 2
  • Physical examination should assess vital signs, height, weight, BMI, and signs of purging behaviors 1
  • Laboratory assessment should include complete blood count, comprehensive metabolic panel, electrolytes, liver enzymes, and renal function tests 1
  • An electrocardiogram is recommended for patients with severe purging behavior 1

First-Line Treatment

Psychological Treatment

  • Eating disorder-focused cognitive-behavioral therapy (CBT) is the cornerstone treatment for bulimia nervosa 1, 2, 3
  • CBT focuses on normalizing eating behaviors and addressing psychological aspects like fear of weight gain and body image disturbance 2, 3
  • For adolescents and emerging adults with involved caregivers, eating disorder-focused family-based treatment is suggested 1

Pharmacological Treatment

  • Fluoxetine at 60 mg/day is the recommended medication, administered in the morning 2, 4
  • This dose was statistically significantly superior to placebo in reducing the frequency of binge-eating and vomiting 4
  • For some patients, it may be advisable to titrate up to the target dose over several days 4
  • Fluoxetine doses above 60 mg/day have not been systematically studied in patients with bulimia 4

Treatment Delivery

  • Treatment should be delivered by a coordinated multidisciplinary team incorporating medical, psychiatric, psychological, and nutritional expertise 1, 3
  • The team typically includes a primary care physician, mental health practitioner, and registered dietitian/nutritionist 3
  • A documented, comprehensive, culturally appropriate, and person-centered treatment plan is essential 1

When First-Line Treatment Fails

  • If there is minimal or no response to psychotherapy alone by 6 weeks, add fluoxetine 60 mg daily 1, 2
  • For patients who don't respond to CBT, more expanded or intensive CBT may be considered 5
  • Systematic evaluation has demonstrated benefit of continuing fluoxetine 60 mg/day for up to 52 weeks in patients who have responded during an 8-week acute treatment phase 4

Technology-Based Interventions

  • Guided computer-based interventions show promise for treating bulimia nervosa and may help overcome barriers such as shame, stigma, and shortage of specialized providers 1, 2
  • Videoconferencing appears to be a promising approach for delivering care 1, 3
  • These technology-based interventions can serve as a first step in a stepped-care model 1

Special Considerations

  • Lower or less frequent dosage of fluoxetine should be used in patients with hepatic impairment 4
  • Lower or less frequent dosage should also be considered for elderly patients and those with concurrent disease or on multiple medications 4
  • Patient compliance is essential for treatment success, especially with technology-based interventions 1
  • Patients should be periodically reassessed to determine the need for maintenance treatment 4

Maintenance Treatment

  • Patients should be maintained on the lowest effective dosage of medication 4
  • Periodic reassessment is necessary to determine the need for continued treatment 4
  • When discontinuing fluoxetine, a gradual reduction in dose rather than abrupt cessation is recommended to minimize discontinuation symptoms 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Approach for Bulimia Nervosa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Eating Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of bulimia nervosa: when CBT fails.

Behaviour research and therapy, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.